Insomnia

References

Key articles

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. (DSM-5). Washington, DC: American Psychiatric Publishing; 2013 (updated 2018).Full text

Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017 Feb 15;13(2):307-49.Full text  Abstract

Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002 Apr;6(2):97-111. Abstract

Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA. 1989 Sep 15;262(11):1479-84. Abstract

Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med. 2007 Aug 15;3(5 suppl):S7-10.Full text  Abstract

Sun J, Kang J, Wang P, et al. Self-relaxation training can improve sleep quality and cognitive functions in the older: a one-year randomised controlled trial. J Clin Nurs. 2013 May;22(9-10):1270-80. Abstract

Brasure M, Fuchs E, MacDonald R, et al. Psychological and behavioral interventions for managing insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med. 2016 Jul 19;165(2):113-24. Abstract

Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016 Jul 19;165(2):125-33.Full text  Abstract

Deschenes CL, McCurry SM. Current treatments for sleep disturbances in individuals with dementia. Curr Psychiatry Rep. 2009 Feb;11(1):20-6.Full text  Abstract

Sin CW, Ho JS, Chung JW. Systematic review on the effectiveness of caffeine abstinence on the quality of sleep. J Clin Nurs. 2009 Jan;18(1):13-21. Abstract

Morgenthaler T, Kramer M, Alessi C, et al. Practice parameters for the psychological and behavioral treatment of insomnia - an update: an American Academy of Sleep Medicine report. Sleep. 2006 Nov;29(11):1415-9.Full text  Abstract

Wilt TJ, MacDonald R, Brasure M, et al. Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med. 2016 Jul 19;165(2):103-12. Abstract

Reynoldson JN, Elliott E Sr, Nelson LA. Ramelteon: a novel approach in the treatment of insomnia. Ann Pharmacother. 2008 Sep;42(9):1262-71. Abstract

Krystal AD, Erman M, Zammit GK, et al. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep. 2008 Jan;31(1):79-90.Full text  Abstract

Mayer G, Wang-Weigand S, Roth-Schechter B, et al. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. Sleep. 2009 Mar;32(3):351-60.Full text  Abstract

Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017 Feb 15;13(2):307-49.Full text  Abstract

Inagaki T, Miyaoka T, Tsuji S, et al. Adverse reactions to zolpidem: case reports and a review of the literature. Prim Care Companion J Clin Psychiatry. 2010;12(6).Full text  Abstract

Reference articles

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. (DSM-5). Washington, DC: American Psychiatric Publishing; 2013 (updated 2018).Full text

2. Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017 Feb 15;13(2):307-49.Full text  Abstract

3. American Academy of Sleep Medicine. The International Classification of Sleep Disorders (ICSD-3). 3rd ed. Westchester, IL: American Academy of Sleep Medicine; 2014.

4. Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014 Nov;146(5):1387-94. Abstract

5. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002 Apr;6(2):97-111. Abstract

6. Johnson EO, Roehrs T, Roth T, et al. Epidemiology of alcohol and medication as aids to sleep in early adulthood. Sleep. 1998 Mar 15;21(2):178-86. Abstract

7. Ford ES, Wheaton AG, Cunningham TJ, et al. Trends in outpatient visits for insomnia, sleep apnea, and prescriptions for sleep medications among US adults: findings from the National Ambulatory Medical Care survey 1999-2010. Sleep. 2014 Aug 1;37(8):1283-93.Full text  Abstract

8. Breslau N, Roth T, Rosenthal L, et al. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996 Mar 15;39(6):411-8. Abstract

9. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry. 1985 Mar;42(3):225-32. Abstract

10. Lindberg E, Janson C, Gislason T, et al. Sleep disturbances in a young adult population: can gender differences be explained by differences in psychological status? Sleep. 1997 Jun;20(6):381-7. Abstract

11. Wickwire EM, Shaya FT, Scharf SM. Health economics of insomnia treatments: the return on investment for a good night's sleep. Sleep Med Rev. 2016 Dec;30:72-82. Abstract

12. Benca RM, Ancoli-Israel S, Moldofsky H. Special considerations in insomnia diagnosis and management: depressed, elderly, and chronic pain populations. J Clin Psychiatry. 2004;65(suppl 8):26-35. Abstract

13. Cochen V, Arbus C, Soto ME, et al. Sleep disorders and their impacts on healthy, dependent, and frail older adults. J Nutr Health Aging. 2009 Apr;13(4):322-9. Abstract

14. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA. 1989 Sep 15;262(11):1479-84. Abstract

15. Pigeon WR, Bishop TM, Krueger KM. Insomnia as a precipitating factor in new onset mental illness: a systematic review of recent findings. Curr Psychiatry Rep. 2017 Aug;19(8):44. Abstract

16. Li L, Wu C, Gan Y, et al. Insomnia and the risk of depression: a meta-analysis of prospective cohort studies. BMC Psychiatry. 2016 Nov 5;16(1):375.Full text  Abstract

17. Richardson JD, Thompson A, King L, et al. Insomnia, psychiatric disorders and suicidal ideation in a National Representative Sample of active Canadian Forces members. BMC Psychiatry. 2017 Jun 6;17(1):211.Full text  Abstract

18. Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep. 1999 May 1;22(suppl 2):S347-53. Abstract

19. Ohayon MM, Roth T. What are the contributing factors for insomnia in the general population? J Psychosom Res. 2001 Dec;51(6):745-55. Abstract

20. Katz DA, McHorney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med. 1998 May 25;158(10):1099-107.Full text  Abstract

21. Mallon L, Broman JE, Hetta J. Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population. J Intern Med. 2002 Mar;251(3):207-16.Full text  Abstract

22. McCracken LM, Iverson GL. Disrupted sleep patterns and daily functioning in patients with chronic pain. Pain Res Manag. 2002 Summer;7(2):75-9. Abstract

23. Mathias JL, Cant ML, Burke ALJ. Sleep disturbances and sleep disorders in adults living with chronic pain: a meta-analysis. Sleep Med. 2018 Dec;52:198-210.Full text  Abstract

24. Nicassio PM, Wallston KA. Longitudinal relationships among pain, sleep problems, and depression in rheumatoid arthritis. J Abnorm Psychol. 1992 Aug;101(3):514-20. Abstract

25. Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med. 2007 Aug 15;3(5 suppl):S7-10.Full text  Abstract

26. Harvey AG. A cognitive model of insomnia. Behav Res Ther. 2002 Aug;40(8):869-93. Abstract

27. Reeve S, Sheaves B, Freeman D. The role of sleep dysfunction in the occurrence of delusions and hallucinations: a systematic review. Clin Psychol Rev. 2015 Dec;42:96-115.Full text  Abstract

28. Gates P, Albertella L, Copeland J. Cannabis withdrawal and sleep: a systematic review of human studies. Subst Abus. 2016;37(1):255-69. Abstract

29. Perney P, Lehert P. Insomnia in alcohol-dependent patients: prevalence, risk factors and acamprosate effect: an individual patient data meta-analysis. Alcohol Alcohol. 2018 Sep 1;53(5):611-8.Full text  Abstract

30. Nierenberg AA, Pava JA, Clancy K, et al. Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes? Biol Psychiatry. 1996 Oct 15;40(8):691-6. Abstract

31. Krystal AD, Thase ME, Tucker VL, et al. Bupropion HCL and sleep in patients with depression. Curr Psych Rev. 2007;3(2):123-8.

32. Doufas AG, Panagiotou OA, Panousis P, et al. Insomnia from drug treatments: evidence from meta-analyses of randomized trials and concordance with prescribing information. Mayo Clin Proc. 2017 Jan;92(1):72-87. Abstract

33. Blanken TF, Benjamins JS, Borsboom D, et al. Insomnia disorder subtypes derived from life history and traits of affect and personality. Lancet Psychiatry. 2019 Feb;6(2):151-63. Abstract

34. Bonnet MH, Arand DL. 24-hour metabolic rate in insomniacs and matched normal sleepers. Sleep. 1995 Sep;18(7):581-8. Abstract

35. Bonnet MH, Arand DL. Physiological activation in patients with sleep state misperception. Psychosom Med. 1997 Sep-Oct;59(5):533-40. Abstract

36. Bonnet MH, Arand DL. Heart rate variability in insomniacs and matched normal sleepers. Psychosom Med. 1998 Sep-Oct;60(5):610-5. Abstract

37. Dodds KL, Miller CB, Kyle SD, et al. Heart rate variability in insomnia patients: a critical review of the literature. Sleep Med Rev. 2017 Jun;33:88-100. Abstract

38. Vgontzas AN, Bixler EO, Lin HM, et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab. 2001 Aug;86(8):3787-94.Full text  Abstract

39. Vgontzas AN, Tsigos C, Bixler EO, et al. Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res. J Psychosom Res. 1998 Jul;45(1):21-31. Abstract

40. Riemann D, Klein T, Rodenbeck A, et al. Nocturnal cortisol and melatonin secretion in primary insomnia. Psychiatry Res. 2002 Dec 15;113(1-2):17-27. Abstract

41. Sánchez-Ortuño MM, Carney CE, Edinger JD, et al. Moving beyond average values: assessing the night-to-night instability of sleep and arousal in DSM-IV-TR insomnia subtypes. Sleep. 2011 Apr 1;34(4):531-9.Full text  Abstract

42. Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Fam Pract. 2002 Mar;51(3):229-35. Abstract

43. Hertenstein E, Feige B, Gmeiner T, et al. Insomnia as a predictor of mental disorders: A systematic review and meta-analysis. Sleep Med Rev. 2019 Feb;43:96-105.Full text  Abstract

44. Léger D, Massuel MA, Metlaine A; SISYPHE Study Group. Professional correlates of insomnia. Sleep. 2006 Feb;29(2):171-8. Abstract

45. Breslau N, Roth T, Rosenthal L, et al. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996 Mar 15;39(6):411-8. Abstract

46. He Q, Zhang P, Li G, et al. The association between insomnia symptoms and risk of cardio-cerebral vascular events: a meta-analysis of prospective cohort studies. Eur J Prev Cardiol. 2017 Jul;24(10):1071-82. Abstract

47. Fernandez-Mendoza J, Vgontzas AN, Liao D, et al. Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension. 2012 Oct;60(4):929-35.Full text  Abstract

48. Suka M, Yoshida K, Sugimori H. Persistent insomnia is a predictor of hypertension in Japanese male workers. J Occup Health. 2003 Nov;45(6):344-50. Abstract

49. Vgontzas AN, Liao D, Pejovic S, et al. Insomnia with objective short sleep duration is associated with type 2 diabetes: a population-based study. Diabetes Care. 2009 Nov;32(11):1980-5.Full text  Abstract

50. Li Y, Zhang X, Winkelman JW, et al. Association between insomnia symptoms and mortality: a prospective study of US men. Circulation. 2014 Feb 18;129(7):737-46.Full text  Abstract

51. Parthasarathy S, Vasquez MM, Halonen M, et al. Persistent insomnia is associated with mortality risk. Am J Med. 2015 Mar;128(3):268-75.Full text  Abstract

52. Jarrin DC, Alvaro PK, Bouchard MA, et al. Insomnia and hypertension: a systematic review. Sleep Med Rev. 2018 Oct;41:3-38. Abstract

53. Zheng B, Yu C, Lv J, et al; China Kadoorie Biobank Collaborative Group. Insomnia symptoms and risk of cardiovascular diseases among 0.5 million adults: a 10-year cohort. Neurology. 2019 Dec 3;93(23):e2110-20. Abstract

54. Lovato N, Lack L. Insomnia and mortality: A meta-analysis. Sleep Med Rev. 2019 Feb;43:71-83.Full text  Abstract

55. de Almondes KM, Costa MV, Malloy-Diniz LF, et al. Insomnia and risk of dementia in older adults: systematic review and meta-analysis. J Psychiatr Res. 2016 Jun;77:109-15. Abstract

56. Shi L, Chen SJ, Ma MY, et al. Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis. Sleep Med Rev. 2018 Aug;40:4-16.Full text  Abstract

57. Wilson S, Anderson K, Baldwin D, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. J Psychopharmacol. 2019 Aug;33(8):923-47.Full text  Abstract

58. Boyd JH, Weissman MM. Epidemiology of affective disorders: a reexamination and future directions. Arch Gen Psychiatry. 1981 Sep;38(9):1039-46. Abstract

59. Johnson EO, Roth T, Schultz L, et al. Epidemiology of DSM-IV insomnia in adolescence: lifetime prevalence, chronicity, and an emergent gender difference. Pediatrics. 2006 Feb;117(2):e247-56.Full text  Abstract

60. Manber R, Bootzin RR. Sleep and the menstrual cycle. Health Psychol. 1997 May;16(3):209-14. Abstract

61. Smagula SF, Stone KL, Fabio A, et al. Risk factors for sleep disturbances in older adults: evidence from prospective studies. Sleep Med Rev. 2016 Feb;25:21-30.Full text  Abstract

62. Gislason T, Reynisdottir H, Kristbjarnarson H, et al. Sleep habits and sleep disturbances among the elderly: an epidemiological survey. J Intern Med. 1993 Jul;234(1):31-9. Abstract

63. Janson C, Lindberg E, Gislason T, et al. Insomnia in men: a 10-year prospective population based study. Sleep. 2001 Jun 15;24(4):425-30. Abstract

64. Leysen L, Lahousse A, Nijs J, et al. Prevalence and risk factors of sleep disturbances in breast cancersurvivors: systematic review and meta-analyses. Support Care Cancer. 2019 Dec;27(12):4401-33.Full text  Abstract

65. Lobo LL, Tufik S. Effects of alcohol on sleep parameters of sleep-deprived healthy volunteers. Sleep. 1997 Jan;20(1):52-9. Abstract

66. Curatolo PW, Robertson D. The health consequences of caffeine. Ann Intern Med. 1983 May;98(5 Pt 1):641-53. Abstract

67. Clark I, Landolt HP. Coffee, caffeine, and sleep: a systematic review of epidemiological studies and randomized controlled trials. Sleep Med Rev. 2017 Feb;31:70-8. Abstract

68. Soldatos CR, Kales JD, Scharf MB, et al. Cigarette smoking associated with sleep difficulty. Science. 1980 Feb 1;207(4430):551-3. Abstract

69. Sandsmark DK, Elliott JE, Lim MM. Sleep-wake disturbances after traumatic brain injury: synthesis of human and animal studies. Sleep. 2017 May 1;40(5).Full text  Abstract

70. Cingi C, Emre IE, Muluk NB. Jetlag related sleep problems and their management: A review. Travel Med Infect Dis. 2018 Jul - Aug;24:59-64.Full text  Abstract

71. Richardson GS, Miner JD, Czeisler CA. Impaired driving performance in shiftworkers: the role of the circadian system in a multifactorial model. Alcohol Drugs Driving. 1989-1990;5-6(4-1):265-73. Abstract

72. Ohayon MM, Lemoine P, Arnaud-Briant V, et al. Prevalence and consequences of sleep disorders in a shift worker population. J Psychosom Res. 2002 Jul;53(1):577-83. Abstract

73. Booker LA, Magee M, Rajaratnam SMW, et al. Individual vulnerability to insomnia, excessive sleepiness and shift work disorder amongst healthcare shift workers. A systematic review. Sleep Med Rev. 2018 Oct;41:220-33.Full text  Abstract

74. Gupta L, Morgan K, Gilchrist S. Does elite sport degrade sleep quality? A systematic review. Sports Med. 2017 Jul;47(7):1317-33.Full text  Abstract

75. Yang Y, Shin JC, Li D, et al. Sedentary behavior and sleep problems: a systematic review and meta-analysis. Int J Behav Med. 2017 Aug;24(4):481-92. Abstract

76. Herscovitch J, Broughton R. Sensitivity of the Stanford sleepiness scale to the effects of cumulative partial sleep deprivation and recovery oversleeping. Sleep. 1981;4(1):83-91. Abstract

77. Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008 Oct 15;4(5):487-504.Full text  Abstract

78. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540-5. Abstract

79. Soldatos CR, Dikeos DG, Paparrigopoulos TJ. The diagnostic validity of the Athens Insomnia Scale. J Psychosom Res. 2003 Sep;55(3):263-7. Abstract

80. Buysse DJ, Reynolds CF 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. Abstract

81. Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001 Jul;2(4):297-307. Abstract

82. Smith MT, McCrae CS, Cheung J, et al. Use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2018 Jul 15;14(7):1231-7.Full text  Abstract

83. Toward Optimized Practice. Assessment to management of adult insomnia. Dec 2015 [internet publication].Full text

84. Littner MR, Kushida C, Wise M, et al; Practice Committee of the American Academy of Sleep Medicine. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep. 2005 Jan;28(1):113-21.Full text  Abstract

85. Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017 Dec;26(6):675-700.Full text  Abstract

86. American Academy of Sleep Medicine. Consumer sleep technology: an American Academy of Sleep Medicine position statement. 2018 [internet publication].Full text

87. Ellis JG, Cushing T, Germain A. Treating acute insomnia: a randomized controlled trial of a "single-shot" of cognitive behavioral therapy for insomnia. Sleep. 2015 Jun 1;38(6):971-8.Full text  Abstract

88. Cheng SK, Dizon J. Computerised cognitive behavioural therapy for insomnia: a systematic review and meta-analysis. Psychother Psychosom. 2012;81(4):206-16. Abstract

89. Morin CM, Vallières A, Guay B, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009 May 20;301(19):2005-15.Full text  Abstract

90. Morin CM, Bootzin RR, Buysse DJ, et al. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep. 2006 Nov;29(11):1398-414. Abstract

91. Mitchell MD, Gehrman P, Perlis M, et al. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Fam Pract. 2012 May 25;13:40.Full text  Abstract

92. Buysse DJ. Insomnia. JAMA. 2013 Feb 20;309(7):706-16.Full text  Abstract

93. Sun J, Kang J, Wang P, et al. Self-relaxation training can improve sleep quality and cognitive functions in the older: a one-year randomised controlled trial. J Clin Nurs. 2013 May;22(9-10):1270-80. Abstract

94. Vitiello MV, McCurry SM, Shortreed SM, et al. Cognitive-behavioral treatment for comorbid insomnia and osteoarthritis pain in primary care: the lifestyles randomized controlled trial. J Am Geriatr Soc. 2013 Jun;61(6):947-56.Full text  Abstract

95. Black DS, O'Reilly GA, Olmstead R, et al. Mindfulness meditation and improvement in sleep quality and daytime impairment among older adults with sleep disturbances: a randomized clinical trial. JAMA Intern Med. 2015 Apr;175(4):494-501.Full text  Abstract

96. Wu JQ, Appleman ER, Salazar RD, et al. Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: a meta-analysis. JAMA Intern Med. 2015 Sep;175(9):1461-72. Abstract

97. Brasure M, Fuchs E, MacDonald R, et al. Psychological and behavioral interventions for managing insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med. 2016 Jul 19;165(2):113-24. Abstract

98. Brasure M, MacDonald R, Fuchs E, et al; Agency for Healthcare Research and Quality. Management of insomnia disorder. Dec 2015 [internet publication].Full text  Abstract

99. Rash JA, Kavanagh VAJ, Garland SN. A meta-analysis of mindfulness-based therapies for insomnia and sleep disturbance: moving towards processes of change. Sleep Med Clin. 2019 Jun;14(2):209-33. Abstract

100. Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016 Jul 19;165(2):125-33.Full text  Abstract

101. Ree M, Junge M, Cunnington D. Australasian Sleep Association position statement regarding the use of psychological/behavioral treatments in the management of insomnia in adults. Sleep Med. 2017 Aug;36(suppl 1):S43-7. Abstract

102. Manber R, Bei B, Simpson N, et al. Cognitive behavioral therapy for prenatal insomnia: a randomized controlled trial. Obstet Gynecol. 2019 May;133(5):911-9.Full text  Abstract

103. Felder JN, Epel ES, Neuhaus J, et al. Efficacy of digital cognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a randomized clinical trial. JAMA Psychiatry. 2020 May 1;77(5):484-92.Full text  Abstract

104. Riemann D, Perlis ML. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev. 2009 Jun;13(3):205-14. Abstract

105. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry. 1994 Aug;151(8):1172-80. Abstract

106. Johnson JA, Rash JA, Campbell TS, et al. A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev. 2016 Jun;27:20-8. Abstract

107. Cheung JMY, Jarrin DC, Ballot O, et al. A systematic review of cognitive behavioral therapy for insomnia implemented in primary care and community settings. Sleep Medicine Reviews. 2019 Apr;44:23-36. Abstract

108. Davidson JR, Dickson C, Han H. Cognitive behavioural treatment for insomnia in primary care: a systematic review of sleep outcomes. Br J Gen Pract. 2019 Sep;69(686):e657-64.Full text  Abstract

109. Koffel E, Bramoweth AD, Ulmer CS. Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review. J Gen Intern Med. 2018 Jun;33(6):955-62.Full text  Abstract

110. Seyffert M, Lagisetty P, Landgraf J, et al. Internet-delivered cognitive behavioral therapy to treat insomnia: a systematic review and meta-analysis. PLoS One. 2016 Feb 11;11(2):e0149139. Abstract

111. van Straten A, van der Zweerde T, Kleiboer A, et al. Cognitive and behavioral therapies in the treatment of insomnia: a meta-analysis. Sleep Med Rev. 2018 Apr;38:3-16. Abstract

112. Zachariae R, Lyby MS, Ritterband LM, et al. Efficacy of internet-delivered cognitive-behavioral therapy for insomnia: a systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2016 Dec;30:1-10. Abstract

113. Deschenes CL, McCurry SM. Current treatments for sleep disturbances in individuals with dementia. Curr Psychiatry Rep. 2009 Feb;11(1):20-6.Full text  Abstract

114. McCurry SM, Gibbons LE, Logsdon RG, et al. Nighttime insomnia treatment and education for Alzheimer's disease: a randomized, controlled trial. J Am Geriatr Soc. 2005 May;53(5):793-802. Abstract

115. Lamarche LJ, De Koninck J. Sleep disturbance in adults with posttraumatic stress disorder: a review. J Clin Psychiatry. 2007 Aug;68(8):1257-70. Abstract

116. Ballesio A, Aquino M, Feige B, et al. The effectiveness of behavioural and cognitive behavioural therapies for insomnia on depressive and fatigue symptoms: a systematic review and network meta-analysis. Sleep Med Rev. 2018 Feb;37: 114-129. Abstract

117. Cunningham JEA, Shapiro CM. Cognitive behavioural therapy for insomnia (CBT-I) to treat depression: a systematic review. J Psychosom Res. 2018 Mar;106:1-12. Abstract

118. Gebara MA, Siripong N, DiNapoli EA, et al. Effect of insomnia treatments on depression: a systematic review and meta-analysis. Depress Anxiety. 2018 Aug;35(8):717-31. Abstract

119. Sin CW, Ho JS, Chung JW. Systematic review on the effectiveness of caffeine abstinence on the quality of sleep. J Clin Nurs. 2009 Jan;18(1):13-21. Abstract

120. Morgenthaler T, Kramer M, Alessi C, et al. Practice parameters for the psychological and behavioral treatment of insomnia - an update: an American Academy of Sleep Medicine report. Sleep. 2006 Nov;29(11):1415-9.Full text  Abstract

121. Chung KF, Lee CT, Yeung WF, et al. Sleep hygiene education as a treatment of insomnia: a systematic review and meta-analysis. Fam Pract. 2018 Jul 23;35(4):365-75. Abstract

122. Feng F, Zhang Y, Hou J, et al. Can music improve sleep quality in adults with primary insomnia? A systematic review and network meta-analysis. Int J Nurs Stud. 2018 Jan;77:189-96. Abstract

123. Morgenthaler T, Kramer M, Alessi C, et al. Practice parameters for the psychological and behavioral treatment of insomnia - an update: an American Academy of Sleep Medicine report. Sleep. 2006 Nov;29(11):1415-9.Full text  Abstract

124. van Straten A, Cuijpers P. Self-help therapy for insomnia: a meta-analysis. Sleep Med Rev. 2009 Feb;13(1):61-71. Abstract

125. Yang PY, Ho KH, Chen HC, et al. Exercise training improves sleep quality in middle-aged and older adults with sleep problems: a systematic review. J Physiother. 2012;58(3):157-63.Full text  Abstract

126. Rubio-Arias JÁ, Marín-Cascales E, Ramos-Campo DJ, et al. Effect of exercise on sleep quality and insomnia in middle-aged women: a systematic review and meta-analysis of randomized controlled trials. Maturitas. 2017 Jun;100:49-56. Abstract

127. Jespersen KV, Koenig J, Jennum P, et al. Music for insomnia in adults. Cochrane Database Syst Rev. 2015 Aug 13;(8):CD010459.Full text  Abstract

128. Taibi DM, Landis CA, Petry H, et al. A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med Rev. 2007 Jun;11(3):209-30. Abstract

129. Meolie AL, Rosen C, Kristo D, et al. Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence. J Clin Sleep Med. 2005 Apr 15;1(2):173-87. Abstract

130. Cooper KL, Relton C. Homeopathy for insomnia: a systematic review of research evidence. Sleep Med Rev. 2010 Oct;14(5):329-37. Abstract

131. Cooper KL, Relton C. Homeopathy for insomnia: summary of additional RCT published since systematic review. Sleep Med Rev. 2010 Dec;14(6):411. Abstract

132. Kalavapalli R, Singareddy R. Role of acupuncture in the treatment of insomnia: a comprehensive review. Complement Ther Clin Pract. 2007 Aug;13(3):184-93. Abstract

133. Lee SH, Lim SM. Acupuncture for insomnia after stroke: a systematic review and meta-analysis. BMC Complement Altern Med. 2016 Jul 19;16:228.Full text  Abstract

134. Cao HJ, Yu ML, Wang LQ, et al. Acupuncture for primary insomnia: an updated systematic review of randomized controlled trials. J Altern Complement Med. 2019 May;25(5):451-74.Full text  Abstract

135. He W, Li M, Zuo L, et al. Acupuncture for treatment of insomnia: an overview of systematic reviews. Complement Ther Med. 2019 Feb;42:407-16.Full text  Abstract

136. Cheuk DK, Yeung WF, Chung KF, et al. Acupuncture for insomnia. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005472.Full text  Abstract

137. Rösner S, Englbrecht C, Wehrle R, et al. Eszopiclone for insomnia. Cochrane Database Syst Rev. 2018 Oct 10;(10):CD010703.Full text  Abstract

138. Herring WJ, Snyder E, Budd K, et al. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology. 2012 Dec 4;79(23):2265-74. Abstract

139. Wilt TJ, MacDonald R, Brasure M, et al. Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med. 2016 Jul 19;165(2):103-12. Abstract

140. Herring WJ, Connor KM, Snyder E, et al. Suvorexant in elderly patients with insomnia: pooled analyses of data from phase III randomized controlled clinical trials. Am J Geriatr Psychiatry. 2017 Jul;25(7):791-802. Abstract

141. Kuriyama A, Tabata H. Suvorexant for the treatment of primary insomnia: a systematic review and meta-analysis. Sleep Med Rev. 2017 Oct;35:1-7. Abstract

142. Everitt H, Baldwin DS, Stuart B, et al. Antidepressants for insomnia in adults. Cochrane Database Syst Rev. 2018 May 14;(5):CD010753.Full text  Abstract

143. Jaffer KY, Chang T, Vanle B, et al. Trazodone for insomnia: a systematic review. Innov Clin Neurosci. 2017 Aug 1;14(7-8):24-34.Full text  Abstract

144. Yi XY, Ni SF, Ghadami MR, et al. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med. 2018 May;45:25-32.Full text  Abstract

145. Pollack M, Kinrys G, Krystal A, et al. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry. 2008 May;65(5):551-62. Abstract

146. Ji JL, Liu WJ, Zhang N, et al. Effects of paroxetine with or without zolpidem on depression with insomnia: a multi-center randomized comparative study [in Chinese]. Zhonghua Yi Xue Za Zhi. 2007 Jun 19;87(23):1585-9. Abstract

147. Fava M, Asnis GM, Shrivastava R, et al. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder. J Clin Psychopharmacol. 2009 Jun;29(3):222-30. Abstract

148. Ensrud KEJ, Sternfeld BL. Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial. Menopause. 2012 Aug;19(8):848-55.Full text  Abstract

149. Stein DJ, Lopez AG, Stein DJ, et al. Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder. Adv Ther. 2011 Nov;28(11):1021-37. Abstract

150. Fava M, Asnis GM, Shrivastava RK, et al. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. J Clin Psychiatry. 2011 Jul;72(7):914-28. Abstract

151. Kinnunen KM, Vikhanova A, Livingston G. The management of sleep disorders in dementia: an update. Curr Opin Psychiatry. 2017 Nov;30(6):491-97. Abstract

152. Bjerre LM, Farrell B, Hogel M, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline. Can Fam Physician. 2018 Jan;64(1):17-27. Abstract

153. McCleery J, Cohen DA, Sharpley AL. Pharmacotherapies for sleep disturbances in dementia. Cochrane Database Syst Rev. 2016 Nov 16;(11):CD009178.Full text  Abstract

154. Buscemi N, Vandermeer B, Friesen C, et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med. 2007 Sep;22(9):1335-50.Full text  Abstract

155. Nowell PD, Mazumdar S, Buysse DJ, et al. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA. 1997 Dec 24-31;278(24):2170-7. Abstract

156. Glass J, Lanctôt KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005 Nov 19;331(7526):1169.Full text  Abstract

157. Moore TJ, Mattison DR. Assessment of patterns of potentially unsafe use of zolpidem. JAMA Intern Med. 2018 Sep 1;178(9):1275-7.Full text  Abstract

158. Andrade C. Sedative hypnotics and the risk of falls and fractures in the elderly. J Clin Psychiatry. 2018 May/Jun;79(3):18f12340.Full text  Abstract

159. Treves N, Perlman A, Kolenberg Geron L, et al. Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis. Age Ageing. 2018 Mar 1;47(2):201-8.Full text  Abstract

160. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA. 1989 Dec 15;262(23):3303-7. Abstract

161. Hanlon JT, Boudreau RM, Roumani YF, et al. Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition study. J Gerontol A Biol Sci Med Sci. 2009 Apr;64(4):492-8.Full text  Abstract

162. Gray SL, Dublin S, Yu O, et al. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. BMJ. 2016 Feb 2;352:i90.Full text  Abstract

163. Neutel CI, Johansen HL. Association between hypnotics use and increased mortality: causation or confounding? Eur J Clin Pharmacol. 2015 May;71(5):637-42. Abstract

164. Patorno E, Glynn RJ, Levin R, et al. Benzodiazepines and risk of all cause mortality in adults: cohort study. BMJ. 2017 Jul 6;358:j2941.Full text  Abstract

165. Dyer O. FDA issues black box warnings on common insomnia drugs. BMJ. 2019 May 10;365:l2165.Full text  Abstract

166. Perlis M, Gehrman P, Riemann D. Intermittent and long-term use of sedative hypnotics. Curr Pharm Des. 2008;14(32):3456-65. Abstract

167. Walsh JK, Soubrane C, Roth T. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients. Am J Geriatr Psychiatry. 2008 Jan;16(1):44-57. Abstract

168. Zammit G, Schwartz H, Roth T, et al. The effects of ramelteon in a first-night model of transient insomnia. Sleep Med. 2009 Jan;10(1):55-9. Abstract

169. Reynoldson JN, Elliott E Sr, Nelson LA. Ramelteon: a novel approach in the treatment of insomnia. Ann Pharmacother. 2008 Sep;42(9):1262-71. Abstract

170. Uchimura N, Ogawa A, Hamamura M, et al. Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study. Expert Rev Neurother. 2011 Feb;11(2):215-24. Abstract

171. Uchiyama M, Hamamura M, Kuwano T, et al. Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia. Sleep Med. 2011 Feb;12(2):119-26. Abstract

172. Liu J, Wang LN. Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis. Int J Clin Pract. 2012 Sep;66(9):867-73.Full text  Abstract

173. Krystal AD, Erman M, Zammit GK, et al. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep. 2008 Jan;31(1):79-90.Full text  Abstract

174. Erman M, Guiraud A, Joish VN, et al. Zolpidem extended-release 12.5 mg associated with improvements in work performance in a 6-month randomized, placebo-controlled trial. Sleep. 2008 Oct;31(10):1371-8.Full text  Abstract

175. Mayer G, Wang-Weigand S, Roth-Schechter B, et al. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. Sleep. 2009 Mar;32(3):351-60.Full text  Abstract

176. Lo HS, Yang CM, Lo HG, et al. Treatment effects of gabapentin for primary insomnia. Clin Neuropharmacol. 2010 Mar-Apr;33(2):84-90. Abstract

177. Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017 Feb 15;13(2):307-49.Full text  Abstract

178. Toward Optimized Practice. Assessment to management of adult insomnia. December 2015 [internet publication].

179. Inagaki T, Miyaoka T, Tsuji S, et al. Adverse reactions to zolpidem: case reports and a review of the literature. Prim Care Companion J Clin Psychiatry. 2010;12(6).Full text  Abstract

180. Lemoine P, Zisapel N. Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia. Expert Opin Pharmacother. 2012 Apr;13(6):895-905. Abstract

181. Richardson G, Wang-Weigand S. Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia. Hum Psychopharmacol. 2009 Mar;24(2):103-11. Abstract

Use of this content is subject to our disclaimer